
Loading, please wait...

Loading, please wait...

Premature infants in the neonatal intensive care unit (NICU) frequently require life-saving respiratory interventions. However, the plastic medical devices (PMDs) used to deliver this care often serve as a hidden source of plasticizer exposure in neonates. Manufacturers add these chemicals, specifically phthalates like di-(2-ethylhexyl) phthalate (DEHP) and alternative plasticizers (APs) like tris-(2-ethylhexyl) trimellitate (TOTM), to increase the flexibility and durability of ventilation circuits. Because these chemicals do not bind covalently to the plastic, they can easily migrate from the devices into the infant\'s system.
A recent study investigated the leaching behavior of nine different phthalates and 11 APs within commonly used respiratory support systems. Initially, researchers identified significant concentrations of TOTM and DEHP within the PMDs themselves. Furthermore, the team utilized a novel ex vivo leaching model to simulate mechanical ventilation conditions. Significantly, the results showed substantial concentrations of DEHP and diethyl phthalate in breath condensate after it circulated through standard ventilation circuits. These findings confirm that even devices labeled as using alternative plasticizers may still contribute to cumulative chemical burdens in vulnerable infants.
Exposure to endocrine-disrupting chemicals during critical windows of development poses serious risks. Specifically, high levels of phthalates correlate with impaired neurodevelopment and potential reproductive toxicity. Therefore, neonatologists must consider the chemical composition of respiratory equipment as part of a holistic approach to infant safety. Transitioning to DEHP-free materials and utilizing alternative plasticizers with lower migration potential, such as TOTM, may offer a pathway to reduce these toxic risks. Ultimately, this research provides a vital framework for assessing clinical migration behavior and improving neonatal outcomes through better device selection.
Respiratory support equipment, including endotracheal tubes and ventilation circuits, represents a major source. Additionally, IV tubing and enteral feeding sets frequently contain phthalates that can leach into fluids.
Research associates heavy plasticizer exposure with endocrine disruption, potential reproductive issues, and altered neurodevelopmental outcomes in preterm populations.
Clinicians can mitigate risks by selecting medical devices labeled as DEHP-free or those utilizing alternative plasticizers like TOTM, which exhibit lower migration rates into biological matrices.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional healthcare consultation. Refer to the latest local and national guidelines for clinical practice.
References
1. Cleys P et al. Respiratory Support as a Source of Plasticizer Exposure in Premature Neonates. J Appl Toxicol. 2026 Feb 22. doi: 10.1002/jat.70115. PMID: 41723877.
2. Panneel L et al. Ongoing exposure to endocrine disrupting phthalates and alternative plasticizers in neonatal intensive care unit patients. Environ Int. 2024 Apr;186:108605.
3. Mallow EB et al. Phthalate Exposures in the Neonatal Intensive Care Unit. Children (Basel). 2021 Apr 21;8(5):317.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


New research highlights how respiratory medical devices leach significant amounts of plasticizers like DEHP and TOTM into premature neonates in the NICU....
6 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today